Form 4 for TTRX Turn Therapeutics Inc.
Accepted 2026-02-04 00:00:00 ET · period of report 2026-01-07 · accession 0001213900-26-011817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | 2026-01-07 | TTRX | Dewhurst Martin William | Dir | A - Grant | $0.00 | +21.9K | 21.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-07 | A | A | 21,882 | $0.00 | 21,882 | D | — | — | (F1) The securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2025 Omnibus Incentive Plan. The 21,882 RSUs included in Column 5 of Table I vest in full on January 7, 2027, subject to the reporting person's continuous service to the Issuer. |